Financial statements Interpharma
Balance sheet data of INTERPHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 6 190 207,63 | 6 838 051,83 | 7 402 544,11 | 7 747 829,59 | 5 860 349,88 | 6 000 969,55 |
| A. Fixed assets | 1 682 371,59 | 1 461 234,12 | 1 368 129,41 | 1 266 338,56 | 1 234 230,56 | 991 207,53 |
| B. Current assets | 4 507 836,04 | 5 376 817,71 | 6 034 414,70 | 6 481 491,03 | 4 626 119,32 | 5 009 762,02 |
| C. Share capital contributions (basic funds) | 0,00 | - | - | - | - | - |
| D. Own shares (stocks) | 0,00 | - | - | - | - | - |
| Total liabilities | 6 190 207,63 | 6 838 051,83 | 7 402 544,11 | 7 747 829,59 | 5 860 349,88 | 6 000 969,55 |
| A. Equity | 4 049 986,84 | 3 951 609,23 | 3 968 577,11 | 3 929 786,97 | 4 429 618,62 | 4 503 417,33 |
| B. Liabilities and provisions for liabilities | 2 140 220,79 | 2 886 442,60 | 3 433 967,00 | 3 818 042,62 | 1 430 731,26 | 1 497 552,22 |
| I. Long-term liabilities | 0,00 | 0,00 | 1 350 000,00 | 546 096,99 | 182 032,47 | 0,00 |
| II. Short-term liabilities | 2 140 220,79 | 2 877 168,68 | 1 718 577,85 | 2 676 026,22 | 958 964,84 | 1 368 035,88 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.